MyndTec Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYTC.CN research report →
Companywww.myndtec.com
MyndTec Inc. , a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States. Its flagship product is MyndMove, a non-invasive functional electrical stimulation-based intervention that uses neuroplasticity mechanisms to stimulate the development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living, as well as offers trained therapists the ability to assist individuals affected with paralysis to enhance voluntary control of their limbs.
- CEO
- Craig Leon
- IPO
- 2022
- HQ
- Mississauga, ON, CA
Price Chart
Valuation
- Market Cap
- $159.38K
- P/E
- -0.13
- P/S
- 1.20
- P/B
- -0.11
- EV/EBITDA
- -0.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.40%
- Op Margin
- -833.15%
- Net Margin
- -824.33%
- ROE
- 85.73%
- ROIC
- 132.91%
Growth & Income
- Revenue
- $111.43K · -18.85%
- Net Income
- $-1,247,407 · 27.62%
- EPS
- $-0.05 · 31.51%
- Op Income
- $-1,226,719
- FCF YoY
- 3.70%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.04
- Beta
- -9.27
- Avg Volume
- 7.47K
Get TickerSpark's AI analysis on MYTC.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MYTC.CN Coverage
We haven't published any research on MYTC.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYTC.CN Report →